A Study Of Pembrolizumab In Combination With Trastuzumab-DM1
Clinical trial NCT03032107 · COMPLETED
Trial details
- NCT number
- NCT03032107
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-17
- Primary completion
- 2020-10-29
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.